Multidrug-resistant bacterial infections in the liver transplant setting - Takeaways - MDSpire

Multidrug-resistant bacterial infections in the liver transplant setting

  • By

  • Alberto Ferrarese

  • Marco Senzolo

  • Lolita Sasset

  • Domenico Bassi

  • Umberto Cillo

  • Patrizia Burra

  • June 25, 2024

  • 0 min

Share

  • 1

    The liver is crucial for immune defense and is affected by cirrhosis-associated immune dysfunction, leading to increased bacterial infections.

  • 2

    Multidrug-resistant organisms (MDRO) infections are a growing public health issue, particularly in liver transplant and hepatology settings.

  • 3

    MDRO infections account for 20-34% of culture-positive bacterial infections in cirrhosis, with significant geographical variability in prevalence.

  • 4

    Risk factors for MDRO infections in end-stage liver disease include repeated hospitalizations, prior antibiotic exposure, and invasive procedures.

  • 5

    Antibiotic overuse and prophylaxis may contribute to MDRO infections, but the relationship remains debated and requires further investigation.

Original Source(s)

Related Content